<DOC>
	<DOCNO>NCT01877473</DOCNO>
	<brief_summary>The hypothesis study facilitate reverse atrial remodel maintenance sinus rhythm week precede ablation make feasible perform simple pulmonary vein isolation ( PVI ) result equivalent superior complex atrial ablation patient persistent AF .</brief_summary>
	<brief_title>Comparison Reverse Remodeling PVI Versus CFAE and/or Linear Lesions PVI Persistent AF</brief_title>
	<detailed_description>Atrial fibrillation ( AF ) common cardiac disorder currently affect 2.3 million U.S. adult expect increase incidence 5.6 million year 2050 . Randomized clinical trial show ablation superior antiarrhythmic drug ( AAD ) maintain sinus rhythm among patient symptomatic predominantly paroxysmal AF . However result catheter ablation persistent AF much low variable , range 20-80 % . Moreover agreed-upon standard ablation approach . Prior study suggest pulmonary vein isolation ( PVI ) alone unacceptably low success rate laboratory supplement approach additional lesion set . These include complex atrial fractionate electrograms ( `` CAFÃ‰ '' ) , autonomic denervation , linear leave atrial ablation roof mitral isthmus , empirical manner stepwise approach . However , strategy time consume prone proarrhythmia , namely post-ablation atrial tachycardia occur incidence range &lt; 5 50 % . The low efficacy PVI alone persistent AF attribute adverse electrical , molecular , structural remodel atrium . Collectively , atrial remodel decrease conduction velocity effective refractory period , result shorten atrial wavelength , increase number stability reentrant wavelet . This cause persistence AF independent focal discharge . Standard PVI address `` focal discharge '' trigger PVs initiate AF necessarily underlie atrial substrate . Based concept , hypothesize successful atrial reverse remodel temporary AAD therapy would facilitate performance PVI alone patient persistent AF . The utilization reverse remodel enhance efficiency , efficacy safety ablation AF test randomized clinical trial .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic persistent AF Failure class I antiarrhythmic drug amiodarone control AF Previous proarrhythmia class III AAD include excessive QT prolongation torsadedepointes Previous AF ablation procedure Congestive heart failure ( NYHA IIIIV functional class ) Left ventricle ejection fraction le 35 % Left atrial diameter &gt; 55 mm Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>persistent AF</keyword>
	<keyword>catheter ablation</keyword>
	<keyword>duration 7 day one year</keyword>
	<keyword>symptom failure least one antiarrhythmic drug</keyword>
</DOC>